These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 13321269)

  • 21. The use of meprobamate and other muscle relaxants in muscle spasm due to rheumatic conditions.
    SMITH RT
    Ann N Y Acad Sci; 1957 May; 67(10):839-52. PubMed ID: 13459156
    [No Abstract]   [Full Text] [Related]  

  • 22. Blind study of an artane-like antispasmodic with and without the addition of a tranquilizing agent or a second antispasmodic.
    BAUER HG; McGAVACK TH
    N Y State J Med; 1958 Jul; 58(14):2375-80. PubMed ID: 13566512
    [No Abstract]   [Full Text] [Related]  

  • 23. Inhibition of pentobarbital and meprobamate metabolism by some 'inducers' of drug-metabolizing enzymes.
    KATO R; VASSANELLI P; CHIESARA E
    Experientia; 1962 Oct; 18():453-4. PubMed ID: 13958402
    [No Abstract]   [Full Text] [Related]  

  • 24. Electromyographic studies on patients treated with meprobamate.
    DICKEL HA; DIXON HH; WOOD J; SHANKLIN JG
    West J Surg Obstet Gynecol; 1956 Apr; 64(4):197-201. PubMed ID: 13312237
    [No Abstract]   [Full Text] [Related]  

  • 25. Chlormezanone: a tranquilizing agent with potent skeletal muscle relaxant properties.
    MULLIN WG; EPIFANO L
    Am Pract Dig Treat; 1959 Oct; 10():1743-7. PubMed ID: 14425186
    [No Abstract]   [Full Text] [Related]  

  • 26. Meprobamate; its pharmacologic properties and clinical uses.
    BERGER FM
    Int Rec Med Gen Pract Clin; 1956 Apr; 169(4):184-96. PubMed ID: 13318731
    [No Abstract]   [Full Text] [Related]  

  • 27. [TRANQUILIZING-NEUROLEPTIC SYNERGISM. USE EMPOLYED IN CURRENT PRACTICE AND IN SPECIALIZED AREAS].
    BROUSSOLLE P; ROSIER Y
    J Med Lyon; 1964 Feb; 45():225-34. PubMed ID: 14347369
    [No Abstract]   [Full Text] [Related]  

  • 28. [Electrophysiological studies on the effects of neuroleptic and tranquilizing substances (phenothiazine, meprobamate) on the spinal motor system].
    BUSCH G; HENATSCH HD; SCHULTE FJ
    Arzneimittelforschung; 1960 Apr; 10():217-23. PubMed ID: 13806368
    [No Abstract]   [Full Text] [Related]  

  • 29. The prudent use of antianxiety drugs.
    Hollister LE
    Ration Drug Ther; 1972 Mar; 6(3):1-6. PubMed ID: 5084614
    [No Abstract]   [Full Text] [Related]  

  • 30. [Neuroleptics, thymoleptics and tranquilizers in neurological therapy].
    Hertrich O
    Bibl Psychiatr Neurol; 1969; 139():88-113. PubMed ID: 4400242
    [No Abstract]   [Full Text] [Related]  

  • 31. Some observations on a sedative and a tranquilizing agent.
    SCHEIFLEY CH
    Proc Staff Meet Mayo Clin; 1959 Aug; 34():408-19. PubMed ID: 14442580
    [No Abstract]   [Full Text] [Related]  

  • 32. PATTERNS OF DRUG USAGE IN A PSYCHIATRIC PATIENT POPULATION.
    SATLOFF A
    Am J Psychiatry; 1964 Oct; 121():382-4. PubMed ID: 14211417
    [No Abstract]   [Full Text] [Related]  

  • 33. Use of a "double-blind" study investigating the clinical merits of a new tranquilizing agent.
    KOTEEN H
    Ann Intern Med; 1957 Nov; 47(5):978-89. PubMed ID: 13470721
    [No Abstract]   [Full Text] [Related]  

  • 34. [THERAPEUTIC EFFECTS OF A HYPNOTIC COMPOUND WITH TRANQUILIZING PROPERTIES].
    CHARRIOT G; LAMBERT PA
    Lyon Med; 1964 Jun; 211():1557-67. PubMed ID: 14161670
    [No Abstract]   [Full Text] [Related]  

  • 35. Meprobamate (equanil) for relief of anxiety and nervous tension from various causes.
    TURVEY SE
    Can Med Assoc J; 1956 Jun; 74(11):863-5. PubMed ID: 13316683
    [No Abstract]   [Full Text] [Related]  

  • 36. [ADJUVANT DRUGS IN THE THERAPY OF STUTTERING].
    SCHILLING A
    HNO; 1963 Oct; 11():300-4. PubMed ID: 14094124
    [No Abstract]   [Full Text] [Related]  

  • 37. [A new combination preparation with anticholinergic-tranquilizing action in the treatment of gastroenteropathy of the hypersecretory-hyperkinetic type and of some painful-spastic visceral states].
    MARINI A
    Gazz Med Ital; 1960 Sep; 119():377-9. PubMed ID: 13766810
    [No Abstract]   [Full Text] [Related]  

  • 38. [On the antiphlogistic effect of 3-phenylpropyl carbamate (MH 532), a new central muscle relaxant with tranquilizing properties].
    BUECH O
    Arch Int Pharmacodyn Ther; 1959 Dec; 123():140-7. PubMed ID: 13805643
    [No Abstract]   [Full Text] [Related]  

  • 39. Premedication for electroshock treatment; effect of meprobamate in 120 psychotic patients.
    THAL N
    Dis Nerv Syst; 1956 Feb; 17(2):52-7. PubMed ID: 13285408
    [No Abstract]   [Full Text] [Related]  

  • 40. Use of meprobamate in the treatment of psychotic patients.
    BARSA JA; KLINE NS
    Am J Psychiatry; 1956 Jun; 112(12):1023. PubMed ID: 13313819
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.